IHAM
KNSA icon

Integral Health Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Integral Health Asset Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-234,830
Closed -$2.28M – 73
2022
Q2 		$2.28M Buy
234,830
+63,830
+37% +$596K 0.47% 56
2022
Q1 		$1.7M Buy
171,000
+31,000
+22% +$328K 0.44% 57
2021
Q4 		$1.65M Buy
+140,000
New +$1.72M 0.46% 58
2021
Q1 		– Sell
-135,000
Closed -$2.38M – 82
2020
Q4 		$2.38M Buy
135,000
+15,000
+13% +$263K 0.71% 43
2020
Q3 		$1.84M Buy
+120,000
New +$2.25M 0.58% 60

Other funds holding KNSA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return